Combined Therapies for Lysosomal Storage Diseases

Area of Science:

• Biochemistry
• Genetics
• Molecular Medicine

Background:

• Lysosomal storage diseases (LSDs) are a group of over 50 genetic disorders.
• These diseases result from lysosomal protein dysfunction, leading to compound accumulation.
• Current treatments face challenges, especially for central nervous system and skeletal manifestations.

Purpose of the Study:

• To review and discuss the current status of combination therapies for LSDs.
• To evaluate the effectiveness of combining different therapeutic approaches for LSDs.
• To highlight the potential of combination strategies based on published data.

Main Methods:

• Literature review of existing studies on LSD combination therapies.
• Analysis of published data on the efficacy and limitations of various treatment combinations.
• Discussion of the molecular basis and clinical outcomes of combined therapeutic strategies.

Main Results:

• No single therapeutic approach effectively corrects all LSD symptoms.
• Combination therapies are emerging as a potential strategy to address complex LSD manifestations.
• Published data suggests that combining treatments may offer improved outcomes for LSD patients.

Conclusions:

• Lysosomal storage diseases require multifaceted treatment strategies.
• Combination therapies hold significant potential for improving the management of LSDs.
• Further research into combined therapeutic approaches is crucial for advancing LSD treatment.